Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)
This grant opportunity aims to speed up the development of reliable biomarkers for Alzheimer's disease and related dementias. These biomarkers are intended to be used in discovering and developing medical treatments, conducting clinical trials, and improving clinical practices. The grant will support the validation of these biomarkers to a high standard, similar to the FDA's Biomarker Qualific…
The goal of this Notice of Funding Opportunity (NOFO) is to accelerate the establishment ofeffective and reliable biomarkers of Alzheimers disease (AD) and AD-related dementias (ADRD) for usein therapy/medical product discovery and development, clinical trials and/or clinical practice. Specific…
Funding Source
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers